Baywood  “making LIFE better”®
Home image Company Information image Contact Us image
Pressroom image International Inquiries image Online Partners image Become a Retailer image Become a Distributor image Become a Gold Leaf Retailer

Baywood Evolution™
Metabolic Burn Tropin EF™
Baywood Solutions®
Original Allergy Formula™
Original Snore Formula™
SuperJoints™

Fat Eliminator

Carb Eliminator™

Maximum Strength Carb Eliminator

Cal-Mag FIZZ™
Single-Dose Cranberry Extract™

CellXcite™

NEW! Magnesium FIZZ ™

Complete La Femme®
Breast & Balance™
Breast & Balance™ Lotion
Lip Maximizing Formula™
Vein Support Formula™
Complete Manicure™
MenoSoothe™
Baywood Purechoice®
Beta•s™
SAMe™
Relora®
Natto-Z™
NEW ! Diosmin™
 


 

image image image

in the news

FOR: Baywood International, Inc.
CONTACT: Neil Reithinger, Chairman & C.E.O. (480) 951-3956
FOR IMMEDIATE RELEASE

EXPORT BUSINESS EXPANDED TO INCLUDE Complete La Femme®

SCOTTSDALE, ARIZONA - July 19, 2001 - Baywood International, Inc. (OTC BB: BYWD) announced the addition of its Complete La Femme® product into Turkey with a population of over 55 million people. Baywood's distributor in Istanbul is an established marketer of pharmaceuticals and dietary products using sales representatives to sell directly to pharmacies and doctors' offices. The distributor reaches over 18,000 pharmacies in Turkey alone. Baywood's distributor launched its patented anti-snore product, Dr. Harris' Original Snore Formula™, in the middle of 2000 and has now added Allbres™, a Complete La Femme® product, to its channels.

"These are two products that have contributed significantly toward our ability to open up distribution channels in the U.S. market. Given the market potential of these product in the U.S., their potential appeal internationally is also significant," stated Karl H. Rullich, Vice-President of International Sales for Baywood. "We are very pleased as to how our distributor in Turkey has committed to promoting our brands," Rullich stated further.

Dr. Harris' Original Snore Formula™ is a patented, all-natural product designed to relieve nighttime snoring, one of the most common quality-of-life problems for adults. Medical authorities have estimated that up to 40% of the U.S. population, or over 100 million people, are chronic, regular snorers. Dr. Harris' Original Snore Formula™ is the only patented product in caplet form on the market that is composed of a combination of herbs and enzymes and that is clinically tested to relieve snoring with 85% to 90% good to excellent results.

Allbres™ is the brand name in Turkey for Baywood's Breast Enhancement Formula under its Complete La Femme® line. The product offers an improved, all-natural way to firmer larger breasts through natural hormone balancing. The product contains a proprietary blend of natural herbs that mimic the activity of human hormones such as estrogen or progesterone, or make proper levels of such hormones more available in the body by normalizing glandular and hormonal activity.


 

 

 

 

 

 

 

 

© 2002-08 Baywood International, Inc. All Rights Reserved. Updated on 04/08/2008
Home | Our Commitment To Change
Investor Relations | Terms Of Use | Webmaster

 

Consumer Hotline: 1-800-418-7169

news archive

Click here to view then entire archive for press releases about Baywood International, Inc.

ABOUT BAYWOOD:
Baywood International, Inc. is a nutraceutical company specializing in the development, marketing and distribution of its own proprietary brands under the names Baywood PURECHOICE® Baywood SOLUTIONS®, Baywood EVOLUTION and Complete La Femme®. The Company's products are distributed through independent and chain health food stores, pharmacies, grocery stores, and other direct-to-consumer channels both internationally and domestically. Contact Baywood International, Inc. at 1-888-350-0799 for more information visit www.bywd.com.

NOTICE:
These press releases may contain forward-looking statements, made in reliance upon Section 21D of the Exchange Act of 1934, which involve known and unknown risks, uncertainties or other factors that could cause actual results to differ materially from the results, performance, or expectations implied by these forward-looking statements. The Issuer’s expectations among other things are dependent upon general economic conditions, continued demand for its products, the availability of raw materials, retention of its key management and operating personnel, as well as other uncontrollable or unknown factors which are more fully disclosed in the Company's Form 10-KSB’s and 10-QSB’s on file with the United States Securities and Exchange Commission.